Staphylococcus lugdunensis septicaemia – endocarditis for sure?

    Authors

    Keywords

    infective endocarditis, epidemiology

    DOI

    https://doi.org/10.15836/ccar2022.213

    Full Text

    **Introduction:** Staphylococcus lugdunensis is a species of coagulase-negative staphylococci (CNS) that causes a variety of infectious diseases, including infective endocarditis (IE), usually in an aggressive form with valve destruction and abscess formation, requiring surgery with a high mortality rate (1). **Case report:** 23-year-old female, with no risk factors, presented in December 2020, with fever up to 40ºC, vomiting and weakness lasting for ten days. Initial laboratory showed leukopenia with elevated C-reactive protein and procalcytonine. The patient was admitted to hospital and without obvious source of infection, treatment with broad spectrum antibiotics (co-amoxiclav and azithromycin) was started. Seven days later there was no clinical improvement. Transthoracic echocardiography (TTE) showed normal morphology of heart valves. As blood cultures were positive on S. lugdunensis, vancomycin was introduced in therapy and more frequent TTE examinations were taken. Three weeks after symptom onset and two weeks after blood cultures were positive, a TTE revealed vegetation, in the atrial aspect of the P3 segment of posterior mitral cusp with eccentric mitral regurgitation and transesophageal echocardiography (TEE) confirmed mitral valve endocarditis. Linezolid was introduced to therapy and patient was referred to cardiac surgery due to persistent septicemia. Intraoperatively, vegetations found on P3 segment of mitral valve with perforation, were excised and A3-P3 segment was reconstructed with pericardial patch, followed by a 30 mm annuloplasty ring. Postoperative course was uncomplicated and antibiotic treatment with cotrimoxazole and rimactan was continued three weeks postoperatively. After one year the patient was stable and TTE showed no mitral valve regurgitation. **Conclusion:** In contrast to other central nervous system (CNS) infections, S. lugdunensis mainly affects native heart valves and is more likely to be acquired through the community without an identifiable source of infection (2). In S. lugdunensis septicemia careful monitoring and more frequent TTE should be obtained. In native valve endocarditis valve repair has been shown as a valuable alternative to valve replacement with decreased morbidity and mortality and no need for anticoagulation (3).

    Literature

    1. Parthasarathy S, Shah S, Raja Sager A, Rangan A, Durugu S. Staphylococcus lugdunensis: Review of Epidemiology, Complications, and Treatment. Cureus. 2020 June 24;12(6):e8801. https://doi.org/10.7759/cureus.8801
    2. Petti CA, Simmon KE, Miro JM, Hoen B, Marco F, Chu VH, et al. Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol. 2008 May;46(5):1780–4. https://doi.org/10.1128/JCM.02405-07
    3. Wang TK, Oh T, Voss J, Gamble G, Kang N, Pemberton J. Valvular repair or replacement for mitral endocarditis: 7-year cohort study. Asian Cardiovasc Thorac Ann. 2014 October;22(8):919–26. https://doi.org/10.1177/0218492314521613
    Cardiologia Croatica
    Back to search

    Staphylococcus lugdunensis septicaemia – endocarditis for sure?

    Extended Abstract
    Issue9-10
    Published
    Pages213
    PDF via DOIhttps://doi.org/10.15836/ccar2022.213
    infective endocarditis
    epidemiology

    Authors

    Mira Stipcevic*ORCIDZadar General Hospital, Zadar, Croatia
    Jogen PatrkORCIDZadar General Hospital, Zadar, Croatia
    Igor RudezORCIDDubrava University Hospital, Zagreb, Croatia
    Vedrana TerkesORCIDZadar General Hospital, Zadar, Croatia
    Zoran BakoticORCIDZadar General Hospital, Zadar, Croatia
    Marin BistirlicORCIDZadar General Hospital, Zadar, Croatia
    Drazen ZekanovicORCIDZadar General Hospital, Zadar, Croatia
    Zorislav SusakORCIDZadar General Hospital, Zadar, Croatia
    Branimir BuksaORCIDZadar General Hospital, Zadar, Croatia
    Stipe KosorORCIDZadar General Hospital, Zadar, Croatia
    Karla SavicORCIDZadar General Hospital, Zadar, Croatia
    Dino MikulicORCIDZadar General Hospital, Zadar, Croatia
    Nikola VerunicaORCIDZadar General Hospital, Zadar, Croatia

    *Correspondence email: mira.stipcevic@gmail.com

    Full Text

    Introduction: Staphylococcus lugdunensis is a species of coagulase-negative staphylococci (CNS) that causes a variety of infectious diseases, including infective endocarditis (IE), usually in an aggressive form with valve destruction and abscess formation, requiring surgery with a high mortality rate (1).

    Case report: 23-year-old female, with no risk factors, presented in December 2020, with fever up to 40ºC, vomiting and weakness lasting for ten days. Initial laboratory showed leukopenia with elevated C-reactive protein and procalcytonine. The patient was admitted to hospital and without obvious source of infection, treatment with broad spectrum antibiotics (co-amoxiclav and azithromycin) was started. Seven days later there was no clinical improvement. Transthoracic echocardiography (TTE) showed normal morphology of heart valves. As blood cultures were positive on S. lugdunensis, vancomycin was introduced in therapy and more frequent TTE examinations were taken. Three weeks after symptom onset and two weeks after blood cultures were positive, a TTE revealed vegetation, in the atrial aspect of the P3 segment of posterior mitral cusp with eccentric mitral regurgitation and transesophageal echocardiography (TEE) confirmed mitral valve endocarditis. Linezolid was introduced to therapy and patient was referred to cardiac surgery due to persistent septicemia. Intraoperatively, vegetations found on P3 segment of mitral valve with perforation, were excised and A3-P3 segment was reconstructed with pericardial patch, followed by a 30 mm annuloplasty ring. Postoperative course was uncomplicated and antibiotic treatment with cotrimoxazole and rimactan was continued three weeks postoperatively. After one year the patient was stable and TTE showed no mitral valve regurgitation.

    Conclusion: In contrast to other central nervous system (CNS) infections, S. lugdunensis mainly affects native heart valves and is more likely to be acquired through the community without an identifiable source of infection (2). In S. lugdunensis septicemia careful monitoring and more frequent TTE should be obtained. In native valve endocarditis valve repair has been shown as a valuable alternative to valve replacement with decreased morbidity and mortality and no need for anticoagulation (3).

    Literature

    1. 1.
      Parthasarathy S, Shah S, Raja Sager A, Rangan A, Durugu S. Staphylococcus lugdunensis: Review of Epidemiology, Complications, and Treatment. Cureus. 2020 June 24;12(6):e8801.DOI
    2. 2.
      Petti CA, Simmon KE, Miro JM, Hoen B, Marco F, Chu VH, et al. Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol. 2008 May;46(5):1780–4.DOI
    3. 3.
      Wang TK, Oh T, Voss J, Gamble G, Kang N, Pemberton J. Valvular repair or replacement for mitral endocarditis: 7-year cohort study. Asian Cardiovasc Thorac Ann. 2014 October;22(8):919–26.DOI